To determine whether PIKFYVE expression specifically in malignant cells predicts clinical outcomes of ICB-treated patients, we exploited published single-cell RNA-sequencing datasets representing cancer patients treated with ICB (45, –47). Here, PIKFYVE is linked to cancer.